Article

A Little Peppermint Oil Goes a Long Way for IBS Patients

Author(s):

Peppermint oil is the latest irritable bowel syndrome (IBS) treatment recommended by gastrointestinal specialists.

Peppermint oil is the latest irritable bowel syndrome (IBS) treatment recommended by gastrointestinal specialists.

According to a previous article published in the European Journal of Gastroenterology and Hepatology, the study authors pursued a meta-analysis of the available options to manage IBS.

The assessment included management options like various prescription therapies such as antispasmodics, antidepressants, and non-prescription options, such as peppermint oil, probiotics, and fiber.

While the other treatment methods had been previously considered, peppermint oil was slightly new on the block and warranted four studies with a total of 392 patients. Results found that three of the four studies received a Jadad score — a scoring system measuring the quality of the study on a scale of 0 to five – of four or higher.

Upon further analysis of all the different IBS management methods, the team noted, “the Highest efficacy is currently found for peppermint oil, followed by psychotherapeutic and psychopharmaceutical interventions and probiotics. Traditional antispasmodic therapy has moderate efficacy, whereas the list of motility-affecting drugs yielded weak clinical results, and therapies of bran and fiber are of no value in IBS.”

Michael S. Epstein, MD, a leading gastroenterologist, concluded in a news release, “These findings maybe somewhat surprising to many people, but there is a growing body of evidence supporting the use of peppermint oil in IBS.”

Despite favorable results, the researchers acknowledged further studies and longer clinical trials with peppermint oil are necessary.

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Satish Rao, MD, PhD | Credit: ACG
Anthony Kerbage, MD | Credit: ResearchGate
© 2024 MJH Life Sciences

All rights reserved.